https://e-journal.unmas.ac.id/index.php/Medicamento <p><a title="Profil Sinta JINTO" href="https://sinta.kemdikbud.go.id/journals/profile/7980" target="_blank" rel="noopener"><strong>Jurnal Ilmiah Medicamento</strong></a> abbreviated as <em>JINTO</em>, with registration number e-ISSN <a title="e-ISSN Jurnal Ilmiah Medicamento" href="https://issn.brin.go.id/terbit/detail/1409274190" target="_blank" rel="noopener">2356-4814</a> is an <strong>open-access</strong> scientific journal in the field of Pharmacy, with a <strong>double-blind review</strong> for peer-review process on manuscripts with at least two reviewers. JINTO has been accredited by ARJUNA indexed <strong>SINTA 4 </strong><em>(<a href="https://drive.google.com/file/d/1Vd3DsOLOw5PUVxJOtpRo5NYBkbhcef5G/view?usp=sharing" target="_blank" rel="noopener">from Vol.5 No.1, 2019 till Vol.9 No.2, 2023</a>)</em>. Initially, JINTO was published by the Akademi Farmasi Saraswati Denpasar, but since the beginning of 2019, the journal publisher has changed to the <a title="Fakultas Farmasi Universitas Mahasaraswati Denpasar" href="http://farmasi.unmas.ac.id/" target="_blank" rel="noopener"><strong>Faculty of Pharmacy, Universitas Mahasaraswati Denpasar</strong>,</a> because the previous publishing institution, the Akademi Farmasi Saraswati Denpasar, has been merged into Universitas Mahasaraswati Denpasar become the Faculty of Pharmacy.</p> <p>JINTO is published every six months (<strong>March </strong>and<strong> September</strong>) and aims to serve updated scientific knowledge for researchers in the pharmaceutical field. JINTO accepts scientific papers, whether original articles or review articles, <strong>covering various fields of pharmaceutical sciences</strong> such as <em>Pharmacology and Toxicology</em>; <em>Clinical and Community Pharmacy</em>; <em>Pharmaceutical Chemistry and Analysis</em>; <em>Pharmaceutical Biology and Natural Products</em>; <em>Pharmaceutical Technology</em>; <em>Pharmaceutical Microbiology and Biotechnology</em>; <em>Regulatory Affairs and Pharmacy Marketing Research</em>; and <em>Alternative medicine</em>.</p> en-US Tue, 06 Dec 2022 08:40:12 +0800 OJS 3.3.0.10 http://blogs.law.harvard.edu/tech/rss 60 https://e-journal.unmas.ac.id/index.php/Medicamento/announcement/view/12 <p>Dear all users and authors of the <strong>Jurnal Ilmiah Medicamento</strong>.</p> <p>As of 2023, the JINTO Editorial Board has decided to apply a publication fee for each article that has been accepted and will be published at JINTO of <strong>300,108</strong> (IDR).</p> <p><strong>All manuscripts that have been submitted to OJS JINTO before this notification</strong> will be subject to the new policy above if it has been decided to be accepted and will be published at JINTO in 2023.</p> <p><strong>Article Submission and Processing Fees remain free of charge.</strong></p> https://e-journal.unmas.ac.id/index.php/Medicamento/announcement/view/12 Tue, 06 Dec 2022 07:48:28 +0800